Mirae Asset Global Investments Co. Ltd. lessened its stake in AdaptHealth Corp. (NASDAQ:AHCO – Free Report) by 26.3% during the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 31,718 shares of the company’s stock after selling 11,347 shares during the quarter. Mirae Asset Global Investments Co. Ltd.’s holdings in AdaptHealth were worth $365,000 as of its most recent filing with the SEC.
Other institutional investors have also modified their holdings of the company. Federated Hermes Inc. raised its stake in shares of AdaptHealth by 672.8% in the 4th quarter. Federated Hermes Inc. now owns 705,125 shares of the company’s stock valued at $5,140,000 after purchasing an additional 613,882 shares in the last quarter. Reinhart Partners LLC. raised its stake in shares of AdaptHealth by 12.2% in the 4th quarter. Reinhart Partners LLC. now owns 4,065,695 shares of the company’s stock valued at $29,639,000 after purchasing an additional 443,518 shares in the last quarter. Charles Schwab Investment Management Inc. raised its stake in AdaptHealth by 21.3% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,040,947 shares of the company’s stock worth $7,589,000 after acquiring an additional 183,135 shares during the period. Vanguard Group Inc. raised its stake in AdaptHealth by 4.3% during the third quarter. Vanguard Group Inc. now owns 8,656,553 shares of the company’s stock worth $78,775,000 after acquiring an additional 355,005 shares during the period. Finally, LGT Capital Partners LTD. raised its stake in AdaptHealth by 79.4% during the fourth quarter. LGT Capital Partners LTD. now owns 1,000,000 shares of the company’s stock worth $7,290,000 after acquiring an additional 442,500 shares during the period. Institutional investors and hedge funds own 82.67% of the company’s stock.
AdaptHealth Price Performance
AHCO opened at $10.64 on Friday. The firm has a market cap of $1.42 billion, a price-to-earnings ratio of -2.02, a price-to-earnings-growth ratio of 0.77 and a beta of 1.10. AdaptHealth Corp. has a fifty-two week low of $6.37 and a fifty-two week high of $15.37. The company’s 50-day moving average price is $10.28 and its 200 day moving average price is $9.43. The company has a quick ratio of 1.11, a current ratio of 1.33 and a debt-to-equity ratio of 1.48.
AdaptHealth (NASDAQ:AHCO – Get Free Report) last posted its earnings results on Tuesday, May 7th. The company reported $0.02 EPS for the quarter, missing the consensus estimate of $0.06 by ($0.04). AdaptHealth had a positive return on equity of 8.47% and a negative net margin of 21.45%. The firm had revenue of $792.50 million during the quarter, compared to the consensus estimate of $771.08 million. As a group, sell-side analysts expect that AdaptHealth Corp. will post 0.82 earnings per share for the current year.
Analysts Set New Price Targets
Separately, Truist Financial reiterated a “buy” rating and set a $13.00 price objective on shares of AdaptHealth in a research note on Wednesday, May 15th. One analyst has rated the stock with a sell rating, one has given a hold rating and three have assigned a buy rating to the company. According to MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $10.70.
View Our Latest Report on AdaptHealth
AdaptHealth Profile
AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.
Featured Articles
Receive News & Ratings for AdaptHealth Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for AdaptHealth and related companies with MarketBeat.com’s FREE daily email newsletter.